PROMISSORY NOTEConvertible Security Agreement • April 16th, 2019 • Precipio, Inc. • Laboratory analytical instruments • New York
THIS 8% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 8% Senior Secured Convertible Promissory Notes of Precipio, Inc., a Delaware corporation, (the “Company”), having its principal place of business at 4 Science Park, New Haven, CT 06511, designated as its 8% Senior Secured Convertible Promissory Notes due 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • April 16th, 2019 • Precipio, Inc. • Laboratory analytical instruments • New York
Precipio, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the date which is six months after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [ ] (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 17. Thi
AMENDMENT AND RESTATEMENT AGREEMENT No.2Amendment and Restatement Agreement • April 16th, 2019 • Precipio, Inc. • Laboratory analytical instruments
This AMENDMENT AND RESTATEMENT AGREEMENT No. 2 (this “Amendment No 2”) is made as of April 16, 2019 between Precipio, Inc., a Delaware corporation (the “Company”) and the Investors set forth in Schedule A attached hereto (each an “Investor” and collectively, the “Investors”).
